PKI-402
PKI-402 is a selective, reversible, ATP-competitive inhibitor of PI3K, including PI3K-α mutants, and mTOR (IC50=2, 3, 7,14 and 16 nM for PI3Kα, mTOR, PI3Kβ, PI3Kδ and PI3Kγ) .
Product Specifications
CAS Number
1173204-81-3
UNSPSC
12352005
Hazard Statement
H302, H410
Target
MTOR; PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/PKI-402.html
Purity
99.17
Solubility
DMSO : 5 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL (ultrasonic)
Smiles
CCN1N=NC2=C1N=C(N=C2N3CCOCC3)C4=CC=C(C=C4)NC(NC5=CC=C(C=C5)C(N6CCN(CC6)C)=O)=O
Molecular Formula
C29H34N10O3
Molecular Weight
570.65
Precautions
H302, H410
References & Citations
[1]Mallon R et al. Antitumor efficacy profile of PKI-402, a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor. Mol Cancer Ther. 2010 Apr;9 (4) :976-84.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MTOR; PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Cytokeratin 7 (KRT7) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI2A2]](https://cdn.genprice.uk/products/937/68dd1b79061270361ea1b61c/imageurl/ta803077am.webp)
TA803077AM 100 µL
Cytokeratin 7 (KRT7) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI2A2]
Sign In for Pricing
View Details 
BNC473795-100 1x 100 µL
GLUT-1 (Tumor Progression and Mesothelioma Marker) (rGLUT1/2476), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
